EVP Quality and Regulatory Aff of Dexcom Inc (30-Year Financial, Insider Trades) Donald Abbey (insider trades) sold 9,766 shares of DXCM on 08/24/2020 at an average price of $424.66 a share. The total sale was $4.1 million.
DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. DexCom Inc has a market cap of $40.76 billion; its shares were traded at around $425.69 with a P/E ratio of 194.39 and P/S ratio of 23.34. GuruFocus has detected 3 severe warning signs with DexCom Inc. .
Directors and Officers Recent Trades:
- SVP, Finance & CAO Jereme M Sylvain sold 600 shares of DXCM stock on 08/24/2020 at the average price of $427.41. The price of the stock has decreased by 0.4% since.
- EVP Strategy and Corporate Dev Steven Robert Pacelli sold 1,531 shares of DXCM stock on 08/24/2020 at the average price of $427.24. The price of the stock has decreased by 0.36% since.
- EVP Chief Commercial Officer Richard Doubleday sold 1,530 shares of DXCM stock on 08/24/2020 at the average price of $427.22. The price of the stock has decreased by 0.36% since.
- EVP Quality and Regulatory Aff Donald Abbey sold 9,766 shares of DXCM stock on 08/24/2020 at the average price of $424.66. The price of the stock has increased by 0.24% since.
- SVP Information Technology Shelly Ramasamy Selvaraj sold 400 shares of DXCM stock on 08/10/2020 at the average price of $439.31. The price of the stock has decreased by 3.1% since.
For the complete insider trading history of DXCM, click here
.
